Answers are grounded in this paper and cite their sources.
Evaluation reveals accurate tumor pHe measurement in a mouse model, indicating potential for cancer diagnosis. This dual approach enhances treatment response monitoring, transforming care strategies.
Motivation: Tumor acidosis is a key biomarker for diagnosing cancer and monitoring treatment response. Non-invasive techniques for measuring tumor extracellular pH (pHe) are limited and not yet clinically routine. Goal(s): This study aimed to evaluate a novel approach using simultaneous PET/MRI with 18F and 68Ga based co-agents to accurately measure tumor pHe. Approach: We synthesized pH-sensitive 68Ga and 18F PET/MRI co-agents and measured tumor pHe in a metastatic breast cancer mouse model with pre- and post-bicarbonate treatment. Results: Both agents successfully measured pHe with promising accuracy. The 18F co-agents demonstrated higher precision, with results closely matching those from gold-standard pH sensors. Impact: This dual PET/MRI approach provides a reliable, non-invasive method for measuring tumor pHe, potentially transforming how tumor acidosis is monitored. It could lead to earlier, more accurate assessments of treatment response, enhancing personalized cancer therapy strategies.
No takes yet. Share an insight, caveat, or question.
Dhakan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: